{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:09:38Z","timestamp":1792789778541,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Administration of Traditional Chinese Medicine\u2013 Joint Project with Zhejiang Provincial Administration of Traditional Chinese Medicine","award":["No.GZY-ZJ-KJ-23009"],"award-info":[{"award-number":["No.GZY-ZJ-KJ-23009"]}]},{"name":"the Basic public welfare research program of Zhejiang Province","award":["No.LY24H270004"],"award-info":[{"award-number":["No.LY24H270004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22093-9","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T04:19:21Z","timestamp":1741580361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vaccination and rheumatoid arthritis: an updated systematic review and meta-analysis of data from 25,949,597 participants"],"prefix":"10.1186","volume":"25","author":[{"given":"Hejing","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoding","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"issue":"10","key":"22093_CR1","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2214-109X(16)30185-1","volume":"4","author":"M Van Boven","year":"2016","unstructured":"Van Boven M, van Lier A. Global trends in vaccination coverage. Lancet Glob Health. 2016;4(10):e670\u20131.","journal-title":"LANCET GLOB HEALTH"},{"key":"22093_CR2","unstructured":"Measuring routine childhood vaccination coverage. in 204 countries and territories, 1980\u20132019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. Lancet 2021, 398(10299):503\u2013521."},{"issue":"8","key":"22093_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.15585\/mmwr.mm7308a3","volume":"73","author":"AM Frutos","year":"2024","unstructured":"Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, et al. Interim estimates of 2023-24 seasonal influenza vaccine Effectiveness - United States. MMWR-Morbid Mortal W. 2024;73(8):168\u201374.","journal-title":"MMWR-MORBID MORTAL W"},{"issue":"2","key":"22093_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41575-021-00570-x","volume":"19","author":"MH El-Sayed","year":"2022","unstructured":"El-Sayed MH, Feld JJ. Vaccination at the forefront of the fight against hepatitis B and C. NAT Rev Gastro Hepat. 2022;19(2):87\u20138.","journal-title":"NAT REV GASTRO HEPAT"},{"issue":"6","key":"22093_CR5","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/hep.32265","volume":"75","author":"WQ He","year":"2022","unstructured":"He WQ, Guo GN, Li C. The impact of hepatitis B vaccination in the united States, 1999\u20132018. Hepatology. 2022;75(6):1566\u201378.","journal-title":"Hepatology"},{"key":"22093_CR6","doi-asserted-by":"publisher","first-page":"m4704","DOI":"10.1136\/bmj.m4704","volume":"371","author":"W Wang","year":"2020","unstructured":"Wang W, Wu Q, Yang J, Dong K, Chen X, Bai X, Chen X, Chen Z, Viboud C, Ajelli M, et al. Global, regional, and National estimates of target population sizes for covid-19 vaccination: descriptive study. BMJ-BRIT Med J. 2020;371:m4704.","journal-title":"BMJ-BRIT MED J"},{"issue":"10255","key":"22093_CR7","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","volume":"396","author":"A de Figueiredo","year":"2020","unstructured":"de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective Temporal modelling study. Lancet. 2020;396(10255):898\u2013908.","journal-title":"Lancet"},{"issue":"10055","key":"22093_CR8","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023\u201338.","journal-title":"Lancet"},{"key":"22093_CR9","first-page":"e70856","volume":"384","author":"P Brown","year":"2024","unstructured":"Brown P, Pratt AG, Hyrich KL. Therapeutic advances in rheumatoid arthritis. BMJ-Brit Med J. 2024;384:e70856.","journal-title":"BMJ-BRIT MED J"},{"issue":"9","key":"22093_CR10","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s10067-023-06628-2","volume":"42","author":"G Shi","year":"2023","unstructured":"Shi G, Liao X, Lin Z, Liu W, Luo X, Zhan H, Cai X. Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the global burden of disease study 2019. Clin Rheumatol. 2023;42(9):2297\u2013309.","journal-title":"CLIN RHEUMATOL"},{"issue":"10391","key":"22093_CR11","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, Mason J, Sattar N, McMurray J, McInnes IB, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878\u201390.","journal-title":"Lancet"},{"issue":"1","key":"22093_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jbspin.2012.02.005","volume":"80","author":"S Dadoun","year":"2013","unstructured":"Dadoun S, Zeboulon-Ktorza N, Combescure C, Elhai M, Rozenberg S, Gossec L, Fautrel B. Mortality in rheumatoid arthritis over the last Fifty years: systematic review and meta-analysis. Joint Bone Spine. 2013;80(1):29\u201333.","journal-title":"JOINT BONE SPINE"},{"key":"22093_CR13","doi-asserted-by":"crossref","unstructured":"Pope JE. Management of fatigue in rheumatoid arthritis. RMD Open 2020, 6(1).","DOI":"10.1136\/rmdopen-2019-001084"},{"key":"22093_CR14","doi-asserted-by":"crossref","unstructured":"Basra G, Jajoria P, Gonzalez E. Rheumatoid arthritis and Swine influenza vaccine: a case report. Case Rep Rheumatol 2012, 2012:785028.","DOI":"10.1155\/2012\/785028"},{"issue":"6","key":"22093_CR15","first-page":"767","volume":"20","author":"DA Geier","year":"2002","unstructured":"Geier DA, Geier MR. A one year followup of chronic arthritis following Rubella and hepatitis B vaccination based upon analysis of the vaccine adverse events reporting system (VAERS) database. Clin Exp Rheumatol. 2002;20(6):767\u201371.","journal-title":"CLIN EXP RHEUMATOL"},{"issue":"10","key":"22093_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/rheumatology\/38.10.978","volume":"38","author":"JF Maillefert","year":"1999","unstructured":"Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B, Juvin R, Parchin-Geneste N, Piroth C, Wendling D, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology. 1999;38(10):978\u201383.","journal-title":"Rheumatology"},{"issue":"9","key":"22093_CR17","first-page":"1687","volume":"25","author":"JE Pope","year":"1998","unstructured":"Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after Recombinant hepatitis B vaccination. J Rheumatol. 1998;25(9):1687\u201393.","journal-title":"J RHEUMATOL"},{"issue":"1","key":"22093_CR18","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1111\/j.1756-185X.2010.01588.x","volume":"14","author":"A Sharma","year":"2011","unstructured":"Sharma A, Agarwal D, Kapoor S, Garg SR, Malaviya AN. Vaccination as a triggering agent for the development of rheumatoid arthritis. INT J Rheum Dis. 2011;14(1):e8\u20139.","journal-title":"INT J RHEUM DIS"},{"issue":"1","key":"22093_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12026-016-8815-9","volume":"65","author":"DA Geier","year":"2017","unstructured":"Geier DA, Geier MR. Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database. Immunol Res. 2017;65(1):46\u201354.","journal-title":"IMMUNOL RES"},{"issue":"19","key":"22093_CR20","first-page":"2324","volume":"136","author":"Y Geng","year":"2023","unstructured":"Geng Y, Fan Y, Wang Y, Deng X, Ji L, Zhang X, Song Z, Huang H, Gui Y, Zhang H, et al. Flare and change in disease activity among patients with stable rheumatoid arthritis following coronavirus disease 2019 vaccination: A prospective Chinese cohort study. Chin Med J-Peking. 2023;136(19):2324\u20139.","journal-title":"Chin MED J-PEKING"},{"issue":"7","key":"22093_CR21","first-page":"681","volume":"14","author":"YC Lai","year":"2015","unstructured":"Lai YC, Yew YW. Severe autoimmune adverse events post herpes Zoster vaccine: A Case-Control study of adverse events in a National database. J Drugs Dermatol. 2015;14(7):681\u20134.","journal-title":"J DRUGS DERMATOL"},{"issue":"2","key":"22093_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/joim.12150","volume":"275","author":"I Persson","year":"2014","unstructured":"Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T, Feltelius N. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med. 2014;275(2):172\u201390.","journal-title":"J INTERN MED"},{"issue":"38","key":"22093_CR23","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1016\/j.vaccine.2011.06.112","volume":"29","author":"P Ray","year":"2011","unstructured":"Ray P, Black S, Shinefield H, Dillon A, Carpenter D, Lewis E, Ross P, Chen RT, Klein NP, Baxter R. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15\u201359 years of age. Vaccine. 2011;29(38):6592\u20137.","journal-title":"VACCINE"},{"issue":"1","key":"22093_CR24","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1038\/s41467-024-50656-8","volume":"15","author":"SW Jung","year":"2024","unstructured":"Jung SW, Jeon JJ, Kim YH, Choe SJ, Lee S. Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study. Nat Commun. 2024;15(1):6181.","journal-title":"NAT COMMUN"},{"issue":"4","key":"22093_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jaad.2023.05.017","volume":"89","author":"HJ Ju","year":"2023","unstructured":"Ju HJ, Lee JY, Han JH, Lee JH, Bae JM, Lee S. Risk of autoimmune skin and connective tissue disorders after mRNA-based COVID-19 vaccination. J Am Acad Dermatol. 2023;89(4):685\u201393.","journal-title":"J AM ACAD DERMATOL"},{"key":"22093_CR26","doi-asserted-by":"publisher","first-page":"1130217","DOI":"10.3389\/fimmu.2023.1130217","volume":"14","author":"G Yang","year":"2023","unstructured":"Yang G, Ren Z, Wang K. Association between human papillomavirus infection or immunization and risk for rheumatoid arthritis. Front Immunol. 2023;14:1130217.","journal-title":"FRONT IMMUNOL"},{"issue":"51","key":"22093_CR27","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1016\/j.vaccine.2008.09.049","volume":"26","author":"T Verstraeten","year":"2008","unstructured":"Verstraeten T, Descamps D, David MP, Zahaf T, Hardt K, Izurieta P, Dubin G, Breuer T. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine. 2008;26(51):6630\u20138.","journal-title":"VACCINE"},{"issue":"10","key":"22093_CR28","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.4161\/21645515.2014.972149","volume":"10","author":"DW Vaughn","year":"2014","unstructured":"Vaughn DW, Seifert H, Hepburn A, Dewe W, Li P, Drame M, Cohet C, Innis BL, Fries LF. Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials. Hum Vacc Immunother. 2014;10(10):2942\u201357.","journal-title":"HUM VACC IMMUNOTHER"},{"issue":"11","key":"22093_CR29","doi-asserted-by":"publisher","first-page":"e50337","DOI":"10.1371\/journal.pone.0050337","volume":"7","author":"TY Ho","year":"2012","unstructured":"Ho TY, Huang KY, Huang TT, Huang YS, Ho HC, Chou P, Lin CH, Wei CK, Lian WC, Chen TC, et al. The impact of influenza vaccinations on the adverse effects and hospitalization rate in the elderly: a National based study in an Asian country. PLoS One. 2012;7(11):e50337.","journal-title":"PLoS ONE"},{"issue":"2","key":"22093_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-2796.2011.02467.x","volume":"271","author":"C Chao","year":"2012","unstructured":"Chao C, Klein NP, Velicer CM, Sy LS, Slezak JM, Takhar H, Ackerson B, Cheetham TC, Hansen J, Deosaransingh K, et al. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012;271(2):193\u2013203.","journal-title":"J INTERN MED"},{"issue":"10","key":"22093_CR31","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1136\/ard.2010.129908","volume":"69","author":"C Bengtsson","year":"2010","unstructured":"Bengtsson C, Kapetanovic MC, K\u00e4llberg H, Sverdrup B, Nordmark B, Klareskog L, Alfredsson L. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2010;69(10):1831\u20133.","journal-title":"ANN RHEUM DIS"},{"issue":"10","key":"22093_CR32","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.7205\/MILMED-D-15-00485","volume":"181","author":"BH Bardenheier","year":"2016","unstructured":"Bardenheier BH, Duffy J, Duderstadt SK, Higgs JB, Keith MP, Papadopoulos PJ, Gilliland WR, McNeil MM. Anthrax vaccine and the risk of rheumatoid arthritis and systemic lupus erythematosus in the U.S. Military: A Case-Control study. MIL MED. 2016;181(10):1348\u201356.","journal-title":"MIL MED"},{"key":"22093_CR33","doi-asserted-by":"publisher","first-page":"f5906","DOI":"10.1136\/bmj.f5906","volume":"347","author":"L Arnheim-Dahlstr\u00f6m","year":"2013","unstructured":"Arnheim-Dahlstr\u00f6m L, Pasternak B, Svanstr\u00f6m H, Spar\u00e9n P, Hviid A. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ-Brit Med J. 2013;347:f5906.","journal-title":"BMJ-BRIT MED J"},{"issue":"5","key":"22093_CR34","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/pds.3554","volume":"23","author":"MG Angelo","year":"2014","unstructured":"Angelo MG, David MP, Zima J, Baril L, Dubin G, Arellano F, Struyf F. Pooled analysis of large and long-term safety data from the human papillomavirus-16\/18-AS04-adjuvanted vaccine clinical trial programme. Pharmacoepidem DR S. 2014;23(5):466\u201379.","journal-title":"PHARMACOEPIDEM DR S"},{"issue":"7","key":"22093_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.autrev.2017.05.012","volume":"16","author":"B Wang","year":"2017","unstructured":"Wang B, Shao X, Wang D, Xu D, Zhang JA. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis. Autoimmun Rev. 2017;16(7):756\u201365.","journal-title":"AUTOIMMUN REV"},{"key":"22093_CR36","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ-Brit Med J. 2021;372:n71.","journal-title":"BMJ-BRIT MED J"},{"issue":"9","key":"22093_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"EUR J EPIDEMIOL"},{"issue":"19","key":"22093_CR38","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF. What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA-J Am Med Assoc. 1998;280(19):1690\u20131.","journal-title":"JAMA-J AM MED ASSOC"},{"issue":"7","key":"22093_CR39","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/SMJ.0b013e31817a7ee4","volume":"101","author":"AJ Viera","year":"2008","unstructured":"Viera AJ. Odds ratios and risk ratios: what\u2019s the difference and why does it matter? South Med J. 2008;101(7):730\u20134.","journal-title":"SOUTH MED J"},{"issue":"8","key":"22093_CR40","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1503\/cmaj.060410","volume":"176","author":"JP Ioannidis","year":"2007","unstructured":"Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. Can Med Assoc J. 2007;176(8):1091\u20136.","journal-title":"CAN MED ASSOC J"},{"issue":"4","key":"22093_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401\u20136.","journal-title":"J CLIN EPIDEMIOL"},{"issue":"8","key":"22093_CR42","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00296-021-04917-0","volume":"41","author":"S Cherian","year":"2021","unstructured":"Cherian S, Paul A, Ahmed S, Alias B, Manoj M, Santhosh AK, Varghese DR, Krishnan N, Shenoy P. Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey. Rheumatol Int. 2021;41(8):1441\u20135.","journal-title":"RHEUMATOL INT"},{"issue":"1","key":"22093_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s42358-023-00335-x","volume":"63","author":"W Yanfang","year":"2023","unstructured":"Yanfang W, Jianfeng C, Changlian L, Yan W. COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease. Adv Rheumatol. 2023;63(1):54.","journal-title":"ADV RHEUMATOL"},{"key":"22093_CR44","doi-asserted-by":"publisher","first-page":"102154","DOI":"10.1016\/j.eclinm.2023.102154","volume":"63","author":"K Peng","year":"2023","unstructured":"Peng K, Li X, Yang D, Chan S, Zhou J, Wan E, Chui C, Lai F, Wong C, Chan E, et al. Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study. Eclinicalmedicine. 2023;63:102154.","journal-title":"ECLINICALMEDICINE"},{"issue":"2","key":"22093_CR45","first-page":"165","volume":"7","author":"S Das","year":"2019","unstructured":"Das S, Ramakrishnan K, Behera SK, Ganesapandian M, Xavier AS, Selvarajan S. Hepatitis B vaccine and Immunoglobulin: key concepts. J Clin Transl Hepato. 2019;7(2):165\u201371.","journal-title":"J CLIN TRANSL HEPATO"},{"key":"22093_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-11-13","volume":"11","author":"B Lu","year":"2011","unstructured":"Lu B, Kumar A, Castellsagu\u00e9 X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.","journal-title":"BMC INFECT DIS"},{"key":"22093_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaut.2017.01.005","volume":"79","author":"L Grimaldi-Bensouda","year":"2017","unstructured":"Grimaldi-Bensouda L, Rossignol M, Kon\u00e9-Paut I, Krivitzky A, Lebrun-Frenay C, Clet J, Brassat D, Papeix C, Nicolino M, Benhamou PY, et al. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance. J Autoimmun. 2017;79:84\u201390.","journal-title":"J AUTOIMMUN"},{"issue":"10","key":"22093_CR48","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s10067-015-2974-2","volume":"34","author":"R Burgos","year":"2015","unstructured":"Burgos R, Ordo\u00f1ez G, V\u00e1zquez-Mellado J, Pineda B, Sotelo J. Occasional presence of herpes viruses in synovial fluid and blood from patients with rheumatoid arthritis and axial spondyloarthritis. Clin Rheumatol. 2015;34(10):1681\u20136.","journal-title":"CLIN RHEUMATOL"},{"issue":"23","key":"22093_CR49","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. New Engl J Med. 2011;365(23):2205\u201319.","journal-title":"NEW ENGL J MED"},{"issue":"7","key":"22093_CR50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/acr2.11064","volume":"1","author":"G Ozen","year":"2019","unstructured":"Ozen G, Pedro S, England BR, Mehta B, Wolfe F, Michaud K. Risk of serious infection in patients with rheumatoid arthritis treated with biologic versus nonbiologic Disease-Modifying antirheumatic drugs. ACR Open Rheumatol. 2019;1(7):424\u201332.","journal-title":"ACR Open Rheumatol"},{"issue":"6","key":"22093_CR51","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1136\/annrheumdis-2016-210708","volume":"76","author":"S Ramiro","year":"2017","unstructured":"Ramiro S, Sepriano A, Chatzidionysiou K, Nam JL, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, Bijlsma JW, Burmester GR, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2017;76(6):1101\u201336.","journal-title":"ANN RHEUM DIS"},{"issue":"1","key":"22093_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","volume":"52","author":"J Listing","year":"2013","unstructured":"Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology. 2013;52(1):53\u201361.","journal-title":"Rheumatology"},{"issue":"3","key":"22093_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/jaut.2000.0478","volume":"16","author":"JF Bach","year":"2001","unstructured":"Bach JF. Protective role of infections and vaccinations on autoimmune diseases. J Autoimmun. 2001;16(3):347\u201353.","journal-title":"J AUTOIMMUN"},{"issue":"Suppl","key":"22093_CR54","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","volume":"25","author":"JF Bach","year":"2005","unstructured":"Bach JF. Infections and autoimmune diseases. J Autoimmun. 2005;25(Suppl):74\u201380.","journal-title":"J AUTOIMMUN"},{"issue":"3","key":"22093_CR55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/08830181003792795","volume":"29","author":"S Salemi","year":"2010","unstructured":"Salemi S, D\u2019Amelio R. Vaccinations and autoimmune diseases. Int Rev Immunol. 2010;29(3):239\u201346.","journal-title":"INT REV IMMUNOL"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22093-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22093-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22093-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T16:05:20Z","timestamp":1741622720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22093-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22093"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22093-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"933"}}